Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:
A venture capital firm made about $470 million on a buzzy biotech's $8 billion acquisition, and has its eye on these promising areas next
Indonesia Berita Berita
Aisling Capital managing partner Steve Elms told Business Insider about the other biotechs and scientific areas the firm is intrigued by.